Antibe Therapeutics Inc. ATBPF
Trading inactive
ATBPF
Antibe Therapeutics Inc. LXXGF
LexaGene Holdings Inc. TMDIF
Titan Medical Inc. VRCDF
Verici Dx plc HOPHF
Hemogenyx Pharmaceuticals Plc CNPOF
RIV Capital Inc. EIGRQ
Eiger BioPharmaceuticals, Inc. LVCLY
Living Cell Technologies Limited RXMD
Progressive Care, Inc. MGCLF
MGC Pharmaceuticals Limited
Antibe Therapeutics Inc. LXXGF
LexaGene Holdings Inc. TMDIF
Titan Medical Inc. VRCDF
Verici Dx plc HOPHF
Hemogenyx Pharmaceuticals Plc CNPOF
RIV Capital Inc. EIGRQ
Eiger BioPharmaceuticals, Inc. LVCLY
Living Cell Technologies Limited RXMD
Progressive Care, Inc. MGCLF
MGC Pharmaceuticals Limited
Performance
| Periode | ATBPF | LXXGF | TMDIF | VRCDF | HOPHF | CNPOF | EIGRQ | LVCLY | RXMD | MGCLF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -0.19 % | -16.91 % | -9.92 % | -74.67 % | 87.90 % | -21.57 % | 255.65 % | -31.45 % | 19.89 % | -24.86 % |
| YTD | -0.19 % | -31.11 % | -44.76 % | -74.67 % | 87.90 % | 0.00 % | 20.57 % | -38.80 % | -36.83 % | -18.06 % |
| 1Y | -0.19 % | -53.68 % | -52.47 % | -74.67 % | 87.90 % | -8.83 % | 3.79 % | -54.33 % | -46.65 % | -94.75 % |
| 3Y | -59.34 % | -78.44 % | -96.83 % | -96.00 % | -58.69 % | -92.86 % | -95.68 % | -69.40 % | 5 310.26 % | -99.32 % |
| 5Y | -95.55 % | -91.24 % | -93.83 % | -97.08 % | 1 692.31 % | -92.66 % | -97.33 % | -69.82 % | 5 452.63 % | -99.28 % |
| 10Y | -83.79 % | -79.85 % | -99.93 % | -97.08 % | 1 692.31 % | -98.85 % | -99.81 % | -93.05 % | 3 416.67 % | -99.33 % |
| From the beginning | -95.48 % | -79.85 % | -93.01 % | -97.08 % | 1 692.31 % | -98.85 % | -99.77 % | -96.81 % | 4 120.00 % | -99.33 % |